RMD FY 2024 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

FY 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.7B+10.9% YoY

Gross Profit

$2.7B56.7% margin

Operating Income

$1.3B28.2% margin

Net Income

$1.0B21.8% margin

EPS (Diluted)

$6.92

Cash Flow

Operating Cash Flow

$1.4B

Free Cash Flow

$1.3B

Stock-Based Comp.

$80M

Balance Sheet

Total Assets

$6.9B

Total Liabilities

$2.0B

Stockholders' Equity

$4.9B

Cash & Equivalents

$238M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.7B	$4.2B	+10.9%
Gross Profit	$2.7B	$2.4B	+12.7%
Operating Income	$1.3B	$1.1B	+16.6%
Net Income	$1.0B	$898M	+13.7%